Secondary macular edema after Descemet*s Stripping Automated Endothelial Keratoplasty (DSAEK): a prospective, non-comparative study.

Secondary macular edema after Descemet*s Stripping Automated Endothelial Keratoplasty (DSAEK): a prospective, non-comparative study. - Post-DSAEK CME

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32110

Enrollment

Registered

2008-09-18

Start date

2009-03-06

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age >= 18 years of age - informed consent - Fuchs* endothelial dystrophy or Pseudophakic Bullous Keratopathy requiring DSAEK - cornea that allows preoperative OCT imaging - pseudophakic

Exclusion criteria

Exclusion criteria: - previous ocular surgery that could influence visual outcome (except uneventful cataract surgery) - other macular or inflammatory disease that could influence the incidence of CME (eg. diabetic retinopathy, diabetic maculopathy, retinal vein occlusion, uveitis) - ocular disease that could influence visual outcome (except Fuchs`endothelial dystrophy or PBK) - other ocular surgery planned within 12 months following inclusion in this study - systemic therapy that could influence the occurrence of macular edema (eg. Avandia, Acetazolamide)

Design outcomes

Primary

Measure	Time frame
Incidence of CME at 1, 3 and 6 months after DSAEK.	—

Secondary

Measure	Time frame
Relationship risk factors and pre-op macular condition with post-op CME.	—

Countries

Netherlands

Outcome results